. 2023 Oct 5;17:17534666231199693. doi: 10.1177/17534666231199693
© The Author(s), 2023
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Figure 1.
Patients on add-on sequential triple combination therapy included in the analysis.